The Stock Market's Movers & Shakers

Stocks finally ran into a little resistance this week, with the major indexes slipping most of the last three days of the holiday week. All told, both the S&P 500 and Nasdaq lost about a half percent for the week, the first lower close in six weeks.

The recent retreat wasn’t surprising—the major indexes had just run straight up into some resistance, and some signs of short-term optimism had arisen. And to this point, the dip (which could easily last another few days or more) has been normal and hasn’t changed the overall picture.

Thus, the intermediate-term trend remains clearly up, and the broad market is still in good shape. Moreover, on an individual stock basis, most Top Ten stocks that have retreated have barely given ground.

On the flip side, the longer-term trend of the major indexes remains down, and most growth-oriented stocks are still on their launching pads. Overall, the number of stocks hitting new highs remains very low, especially on the Nasdaq, which has seen an average of just 40 or so new highs each day during the past three weeks.

Going forward, on the bull side, we’ll continue to take our cue mostly from individual stocks—if more stocks break out on the upside, it will be a bullish sign for the market. As for the long-term trend, we’ll need to see the Nasdaq close a couple of straight weeks above 4,820 or so (its 35-week moving average) before declaring the major trend up.

On the downside, there’s plenty of room for the indexes to dip without damaging the intermediate-term uptrend, but we’ll be watching some sectors (especially the financials) for any major breakdowns. And, of course, if a bunch of Top Ten stocks begin to keel over, that would be a yellow flag as well.

For now, though, we’re sticking with our stance—we’re more invested than not, but we still have a good-sized cash position on the sideline. During the past 18 months, we’ve seen many promising market rallies peter out after four or five weeks, so it’s best to wait for more upside confirmation before getting out-and-out bullish.

This is an excerpt from Cabot Top Ten Trader, which features the best trades to make every week.  Designed for experienced investors who want even more great growth stock ideas, this advisory recommends the best 10 stocks each month for short-term investment by aggressive growth investors.

Michael Cintolo is Cabot's Vice President of Investments and Chief Analyst of Cabot Growth Investor and Cabot Top Ten Trader. To read customer reviews of Cabot Top Ten Trader, click here. To read reviews of Cabot Growth Investor, click here.

Michael Cintolo can be found on Google Plus.

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.


Biogen is the market-share leader in treating multiple sclerosis.


One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >